July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Future therapy: cell-based therapy and drug treatment
Author Affiliations & Notes
  • Naoki Okumura
    Biomedical Engineering, Doshisha University, Kyotanabe, Japan
  • Footnotes
    Commercial Relationships   Naoki Okumura, Doshisha University (P), SENJU Pharmaceutical Co.,Ltd (P)
  • Footnotes
    Support  Program for the Strategic Research Foundation at Private Universities from MEXT (Koizumi, N. and Okumura, N.).
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3916. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Naoki Okumura; Future therapy: cell-based therapy and drug treatment. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3916.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Modern corneal transplantation techniques provide excellent clinical outcomes post surgery. However, we are focused on generating new therapeutic modalities with higher effectiveness and less invasiveness. For example, we initiated the clinical research of a cell-based therapy for treating corneal endothelial decompensation. In addition, we are currently in the process of developing a pharmaceutical treatment. In this presentation, I will introduce our example, and provide a platform for debate about future therapy for treating Fuchs endothelial corneal dystrophy.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.